GuideMedically reviewed Apr 2026

Should I Go to the ER for a Mole? A Practical Decision Guide

It is 11pm, you have noticed something on a mole, and you are wondering whether to drive to the ER. Almost no mole is an ER emergency. A small number of situations genuinely need same-day care, and a slightly larger number need a fast dermatology referral within days. This guide gives you a clear decision tree so you do not waste an ER visit on something that could wait until morning, and you do not wait until next week on something that needs faster care.

Almost no mole is an ER emergency. Here is why.

The emergency department is staffed and resourced for life-threatening, time-critical problems: heart attacks, strokes, severe injuries, sepsis, breathing failure. Skin cancer is rarely time-critical at the hour level. Even the most aggressive melanoma does not change clinically meaningful state between 11pm tonight and 9am tomorrow.

More practically, ER doctors are not skin cancer specialists. They can rule out infection, control bleeding, and refer onward. They cannot biopsy a suspicious mole, do dermoscopy, or stage melanoma. A 4-hour ER visit for a worrying mole almost always ends with the same advice: 'see a dermatologist this week.' That advice is also available without the ER visit.

Which means: the question is not 'is this a real concern,' it is 'what level of care matches this concern's actual urgency.' Most worrying moles need a dermatology appointment in the next 1-4 weeks, not an ER tonight.

Genuine ER situations (rare)

Go to the ER tonight if any of these is happening:

1. Heavy bleeding from a mole or skin lesion that does not stop after 20 minutes of firm continuous pressure. Direct pressure stops most bleeding. Persistent bleeding through pressure can mean a deeper vessel involvement that needs cauterisation.

2. Signs of serious infection from a mole site or recent biopsy site: spreading red streaks moving away from the wound (lymphangitis), high fever (38.5°C / 101°F or higher) with the wound clearly inflamed, sudden severe swelling, or pus combined with severe pain.

3. Allergic-type reaction with breathing or swallowing problems after applying any product to a mole or after an in-clinic procedure. Difficulty breathing, throat tightness, or full-body hives is anaphylaxis and is an immediate ER situation.

4. Sudden very severe pain at a mole or recent biopsy site that does not respond to standard analgesia, especially with fever — could indicate deep tissue infection.

None of these are about the cancer risk of the mole. They are about acute complications. Cancer risk itself is never an ER reason.

Urgent care (same day, not ER) situations

Go to urgent care or call your GP/derm for an emergency same-day appointment if:

1. Bleeding that stops with 10-20 minutes of pressure but starts again repeatedly through the day. Not life-threatening, but needs proper closure or cauterisation.

2. A biopsy site that is moderately infected — increasing redness, mild fever (37.5-38.5°C / 99.5-101.5°F), pus, but no spreading red streaks or severe pain. Antibiotics may be needed; this is appropriate at urgent care.

3. A mole or lesion that has bled, is now stopped, but you cannot get the bleeding to stay stopped through normal activity. Cauterisation in urgent care will resolve.

4. A new lesion in someone with prior advanced melanoma where you want a same-day expert eyes — call the oncology centre directly rather than urgent care if the relationship exists.

For genuine cancer-risk concerns without acute bleeding or infection, urgent care is rarely the right level of care. Urgent care doctors will refer to dermatology in nearly every case. A direct dermatology call the next morning is more efficient.

Fast-track dermatology (within 1-2 weeks) situations

Skip the ER, skip urgent care, but do not wait for the routine next-available slot. Call the dermatologist in the morning and ask for the earliest appointment, ideally within 7-14 days. Mention the specific feature that prompted the call.

Fast-track features:

A mole has changed visibly in the past 4 weeks (size, shape, colour) and meets ABCDE criteria. New asymmetry, new colour variation, sudden growth.

A pigmented streak under a fingernail or toenail, especially if the pigment extends onto the surrounding skin (Hutchinson sign).

A non-healing sore, ulcer, or scab that has not closed in 4+ weeks.

A new pigmented lesion in someone with prior melanoma.

A rapidly growing pink, red, or skin-coloured nodule (possible amelanotic melanoma or Merkel cell carcinoma).

Spontaneous bleeding from a mole or lesion (not from injury) that has happened more than once.

Any of these warrants the call. If your dermatologist's schedule is more than 4 weeks out, ask the GP for an urgent suspected cancer referral — most healthcare systems have a 2-week pathway for skin cancer suspicions.

Routine appointment (within 4-6 weeks) situations

Most mole concerns fall here. The lesion is worth showing to a dermatologist, but it does not need same-day or same-week attention. The 4-6 week window allows for normal scheduling and does not change the clinical outcome.

Routine features:

A mole that you have noticed but cannot remember whether it has changed.

A mole that meets one ABCDE criterion mildly but no others (a slightly larger than 6mm round symmetric mole, for example).

A new mole in an adult that does not have other concerning features and has been stable for the past 1-2 weeks of observation.

A pigmented lesion in someone without specific risk factors that you want professional reassurance about.

General skin check after years of not having one.

Between booking the appointment and the visit, photograph the mole today with a coin for scale. If it changes between now and the appointment, that information is more useful than a verbal description.

Wait and watch (no appointment needed yet) situations

Some mole observations do not need an appointment at all in the short term. They need a 4-week monitoring period and then a re-decision.

Wait and watch is reasonable when:

The mole has been present and stable for years.

No ABCDE feature is met clearly.

No bleeding, no growth, no symptoms.

You have no specific risk factors (no melanoma history, no family history, normal skin type, no immunosuppression).

Anxiety is the primary reason you noticed it now, not an actual change.

The protocol: photograph today with a coin for scale, mark the date, set a reminder for 4 weeks. At 4 weeks, retake the photo. If unchanged, continue monthly self-exams as normal. If changed, book a routine dermatology appointment with the photo evidence.

This is not 'ignore it.' It is 'observe in a structured way that produces real information.' A mole observed once and forgotten is not monitored. A mole photographed today and re-photographed at 4 weeks is monitored.

If you genuinely cannot decide which level fits

Two practical options.

First option: call your dermatologist's after-hours line or the practice's nurse triage. Most have one. Describe the lesion in plain terms and let a clinician decide whether to bring you in tomorrow, next week, or to wait for routine. This is what triage lines exist for.

Second option: in countries with telehealth, a same-day virtual visit costs $30-100 and gets eyes on the lesion within hours. The virtual provider cannot biopsy but can stratify urgency and refer to the right level of care. For 3 AM anxiety, this is often the right balance — it gets a clinical answer faster than a morning derm call without the cost and delay of an ER visit.

What does not work as a substitute: searching forums, posting photos on Reddit, or asking general AI chatbots. These give variable answers driven by the loudest example in their training data. A clinician with your photo and history will give a more accurate triage than a public forum.

Run our free ABCDE checker on the lesion. The checker plus this guide will usually tell you whether you need ER tonight (almost never), fast-track derm (within 1-2 weeks), or routine appointment (within 4-6 weeks).

Start free ABCDE check

Sources

Content based on clinical guidelines from the American Academy of Dermatology (AAD), British Association of Dermatologists (BAD), and peer-reviewed literature from JAAD, BJD, and JAMA Dermatology. Epidemiological data from NCI SEER and IARC GLOBOCAN. Full methodology